Oncology

Audio Journal of Oncology in Advance - March 15th, 2008

March 16, 2008 ⋅ Post a comment

Volume 16 Number 6 (March 15th, 2008) reporting from:
4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris)
American Society of Hematology Annual Meeting (December 8-11, 2007 Atlanta)
Chemotherapy Foundation Symposium, November 7-10, 2007, New York

David Maloney
David Maloney

Nonmyeloablative Alogeneic Transplants Ready for Prime-Time in Follicular Lymphoma?

David Maloney, Fred Hutchinson Cancer Research Center, Seattle
Allogeneic transplantation is now a good option for treating some patient groups with follicular lymphoma. David Maloney explained to Peter Goodwin in Paris how his group has harnessed graft-versus-tumor effect by using nonmyeloablative conditioning without causing unacceptable risks of graft-versus-host disease.

Carolyn Krasner
Carolyn Krasner

Trabectedin Activity in Platinum-Sensitive Relapsed Ovarian Cancer

Carolyn Krasner, Massachusetts General Hospital, Boston
Could trabectedin, which has a novel mechanism of action, be a useful agent for patients with relapsed ovarian cancer? Derek Thorne discussed this question in New York with Carolyn Krasner, whose data show the greatest benefit in patients who are sensitive to platinum agents.

Kirk Schultz
Kirk Schultz
Armand Keating
Armand Keating

High-Dose Chemotherapy Plus Imatinib Benefits Pediatric Acute Lymphoblastic Leukemia

Kirk Schultz, British Columbia Children’s Hospital, Vancouver
COMMENT: Armand Keating, Princess Margaret Hospital, Toronto
For children with acute lymphoblastic leukemia, high-dose chemotherapy combined with imatinib appears to show a survival benefit. Sarah Maxwell spoke with study author Kirk Schultz at the ASH meeting in Atlanta, and Armand Keating provided comment.

John Gribben
John Gribben

Chronic Lymphocytic Leukemia: New Options After Fludarabine Failure

John Gribben, Bartholemews Hospital, London
New treatments for chronic lymphocytic leukemia were discussed in Paris by John Gribben. He gave Peter Goodwin his assessment of antibody therapies such as rituximab and alemtuzumab and new drugs such as lenalidomide, and combinations including standard fludarabine therapy.

To subscribe to the ASCO Audio Journal of Oncology podcast please go to ASCO Audio Journal of Oncology in Advance Presentations or click here.
Download this interview

Similar Interviews

  • When Good Cells Go Bad: The Stem Cell Origin of Cancers

    • DAVID JABLONS, University of California, San Francisco REFERENCE: Keynote Lecture, Perspectives in Lung Cancer Conference, 2-3 March 2007, Seville, Spain Cell signalling

  • Audio Journal of Oncology in Advance - April 15th, 2007 - Bisphosphonates Recommended for Lung Cancer Bone Metastases

    • PETER HARPER, Guy’s Hospital, London REFERENCE: “Management of Tumour and Treatment Related Symptoms” section, Perspectives in Lung Cancer, Seville Bisphosphonates may be

  • Audio Journal of Oncology in Advance - January 15th, 2007 - HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer

    • IAN SMITH, Royal Marsden Hospital, London REFERENCE: Lancet 369:29 Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for early breast

    Post a comment

    British National Health Service is 60!»
    Virginia Berridge, Jerry Morris, Nick Mays, and Nick Black
    Virginia Berridge, Jerry Morris, Nick Mays, and Nick Black of The London School of Hygiene and Tropical Medicine
    LSHTM Audio News British National Health Service is 60! July 5th, 2008 is the 60th birthday of the British National Health Service. Peter Goodwin talks to four experts at the London School of Hygiene and Tropical Medicine to find out how it achieved the almost universal approval it enjoys in the UK, while asking what the future holds in store.
    Obesity, Car Travel, Climate Change: Linked?»
    Phil Edwards, London School of Hyugiene and Tropical Medicine
    LSHTM Audio News Obesity Linked to Motor Transport And Climate Change Peter Goodwin questions Phil Edwards of the London School of Hygiene and Tropical Medicine about "competition between stomachs and petrol tanks" discussed in a letter he and his colleague Ian Roberts have written to the medical magazine: The Lancet.
    Subscribe to Audio Medica Podcast